Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinoma

Gynecologic Oncology

Volumn 45, Issue 3, 1992, Pages 284-289

  Hakes, Thomas B ^a   Chalas, Eva ^a   Hoskins, William J ^a   Jones, Walter B ^a   Markman, Maurie ^a   Rubin, Stephen C ^a   Chapman, Douglass ^b   Almadrones, Lois ^a   Lewis Jr , John L ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CREATININE; CYCLOPHOSPHAMIDE; DOXORUBICIN;

ADULT; ADVANCED CANCER; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER SURVIVAL; CREATININE BLOOD LEVEL; DRUG RESPONSE; FEMALE; FEVER; HISTOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LAPAROTOMY; MAJOR CLINICAL STUDY; NEPHROTOXICITY; OVARY CANCER; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SECOND LOOK SURGERY; TREATMENT PLANNING; TUMOR VOLUME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMAN; LAPAROTOMY; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL ANALYSIS;

EID: 0026720218     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/0090-8258(92)90305-3     Document Type: Article

References (20)

1. Prolonged combination chemotherapy for ovarian carcinoma does not increase the rate of surgical complete remission
2. Advanced ovarian cancer: Brief intensive combination chemotherapy and second-look operation
3. Randomized trial comparing two combination chemotherapy regimens (CAP-5 v CP) in advanced ovarian carcinoma
4. Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: A Gynecologic Oncology Group study
5. Randomized comparison of cisplatin with cyclophosphamide/cisplatin and with cyclophosphamide/doxorubicin/cisplatin in advanced ovarian cancer
6. Nonparametric estimation from incomplete observations
7. A randomized trial of six versus twelve cycles of cyclophosphamide, adriamycin in advanced ovarian cancer
8. Long-term versus short-term chemotherapy in advanced ovarian cancer
9. The role of maintenance therapy in disseminated testicular cancer
10. VAB-6: An effective chemotherapy regimen for patients with germ cell tumors
11. Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer
12. Duration of therapy in adjuvant chemotherapy trials
13. Adjuvant trial of 12 cycles of CMFPT followed by observation or continuous tamoxifen versus four cycles of CMFPT in postmenopausal women with breast cancer: An Eastern Cooperative Oncology Group phase III study
14. Consequences of the chemotherapy of Hodgkin's disease
15. Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphoma
16. Early intensification and short-term maintenance chemotherapy does not prolong survival in acute myelogenous leukemia
17. Prolonged unmaintained remission after intensive consolidation therapy in adult acute nonlymphocytic leukemia
18. Randomized study of 3 years versus 5 years of chemotherapy in childhood acute lymphoblastic leukemia